Hospital Universitari i Politècnic La Fe
Hospital Universitari i Politècnic La Fe
Valencia, Valencia, Spain12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-10-06 | NCT07384715 | |
| Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma | Low Grade Upper Tract Urothelial Carcinoma | Recruiting | Phase 2 | 2026-10-02 | NCT07265947 | |
| Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Not stated | 2026-06-03 | NCT07624838 | |
| Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction | Arrhythmias, Cardiac, Bradycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-05-15 | NCT07585799 | |
| VOLT CE Mark Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation | Active, not recruiting | Not applicable | 2026-05-06 | NCT06106594 | |
| Perceptions of Key Domains of Home-Based Palliative Care Among Healthcare Professionals (MULTIPAL) | Decision Making; Health Services Research; Home Care, Hospital-Based; Palliative Care | Enrolling by invitation | Not stated | 2026-04-28 | NCT07554209 | |
| Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not stated | 2026-01-07 | NCT03876054 | |
| Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2025-09-29 | NCT04595266 | |
| Prehabilitation and Posttransplant Training Program in Liver Transplantation | Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cirrhosis of liver, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Enrolling by invitation | Not applicable | 2025-09-15 | NCT04246970 | |
| Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome with excess blasts-2, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-08-26 | NCT03850574 | |
| The Left Bundle Cardiac Resynchronization Therapy Trial | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Left Bundle-Branch Block, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Ventricular Dysfunction, Ventricular Dysfunction, Left, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure, progressive familial heart block, type 1A | Active, not recruiting | Not applicable | 2025-07-17 | NCT05434962 | |
| Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments | Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Phase 3 | 2024-10-01 | NCT05769868 |